Dear Dr. Pavel Franzevich Zabrodskii,
Warm greetings from the whole team of “Journal of Drug Design and Discovery Research” “SciTech Central Inc., USA”
At the outset, we acknowledge and really appreciate your work and quality of research in the field of Drug Design and Discovery Research.
We have gone through one of the ‘Research Article’ entitled “The effect of chronic intoxication with 2-chloroethanol on immune responses, function of Th1 and Th2 lymphocytes and blood cytokine concentrations” we were intrigued by your article. Our Editorial Board suggested us to invite you to write a similar Research /Review/Case Report or any new article to be published in our journal.
I would like to invite you to contribute a paper for publication in our upcoming issue of Journal of Drug Design and Discovery Research. Research/ Review/ Short Communication/Case study/ commentary etc. are welcome for possible publication in this issue. If you have any Manuscript ready, we request you to support our Journal by submitting the manuscript as soon as possible. Or, I would appreciate receiving your convenient date of submission.
The Journal includes a wide range of fields such as designing new drugs, research and developments, clinical experiments, drug delivery systems, and adverse events, biochemistry and pharmacological aspects.
You may submit your paper by e-mail at dr.jessicaalexis725@scitcentral.org & submissions@scitcentral.com.
The deadline for the submission of your article April 19th, 2023.
Thank you for your time and consideration in this matter.
For any information, please refer to the Authors' Guidelines of the Journal.
We have recently launched our International Conferences in various fields of science and research. Please go through2154
the website of our International Conferences and let us know if you are interested:
www(dot)scitcentralconferences(dot)com
We look forward to hearing from you soon!!!!!
Best Regards
Dr. Jessica Alexis
Editorial Assistant
Journal of Drug Design and Discovery Research
International Journals
SciTech Central Inc.,
USA.